Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 358Precursor Cell Lymphoblastic Leukemia-Lymphoma 164Leukemia 160Lymphoma 109Myelodysplastic Syndromes 74Lymphoma, Non-Hodgkin 66Lymphoma, Large B-Cell, Diffuse 61Lymphoma, Mantle-Cell 59Burkitt Lymphoma 58Recurrence 56Congenital Abnormalities 44Leukemia, Monocytic, Acute 39Lymphoma, Follicular 37Hodgkin Disease 35Leukemia, Myelomonocytic, Acute 34Leukemia, Erythroblastic, Acute 34Leukemia, Megakaryoblastic, Acute 32Blast Crisis 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 26Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia, Biphenotypic, Acute 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, B-Cell, Marginal Zone 19Anemia, Refractory, with Excess of Blasts 19Myeloproliferative Disorders 17Lymphoma, B-Cell 17Leukemia, Myeloid, Accelerated Phase 16Neoplasm, Residual 15

Interventions

fludarabine phosphate 4Cyclophosphamide 3Whole-Body Irradiation 2Mycophenolic Acid 2Etoposide 2pevonedistat 1obinutuzumab 1nelarabine 1letermovir 1ibrutinib 1carmustine, poliferprosan 20 drug combination 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Pharmacogenomic Variants 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Leukapheresis 1Hematopoietic Stem Cell Transplantation 1Cytarabine 1Cyclosporins 1Cyclosporine 1Carmustine 1Blood Component Removal 1Biopsy 1Bendamustine Hydrochloride 16-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Prolymphocytic, B-Cell × Cytarabine × Clear all
NCT01008462 2019-06-11

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
16 enrolled 15 charts
LymphoidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡